In addition, BTK, which is expressed in about 80% of human AML, mediates FLT3-ITD-dependent Myc and STAT5 activation (17), and transcriptionally increases the levels of G1 cell cycle checkpoint proteins through c-Myc signaling (39). The gene discussed is MYC; the disease is acute myeloid leukemia.